All In MedTech

FDA Clearance Tracker · P000025-S035

COMBI 40+ COCHLEAR IMPLANT SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 19, 2008 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 19, 2008

Approved

Time to decision

177 days

Received Jun 25, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P000025-S035
Device name
COMBI 40+ COCHLEAR IMPLANT SYSTEM
Applicant
Med-El Corp.
Applicant location
Innsbruck
Received
Jun 25, 2008
Decided
Dec 19, 2008
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P000025

Device type

Device class
Class III

Every decision under product code MCM

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE MAESTRO SYSTEM SOFTWARE VERSION 3.0 AS EXTERNAL SOFTWARE FOR USE WITH THE MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM, INCLUDING REMOVAL OF THE CURRENT RESTRICTION REGARDING USE OF THE FSP CODING STRATEGY BY INEXPERIENCED ADULT USERS.

Source documents

Other decisions for Med-El Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.